• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于网络药理学、分子对接的MBZM-N-IBT对关节炎作用的分析

Network Pharmacology, Molecular Docking and -based Analysis on the Effects of the MBZM-N-IBT for Arthritis.

作者信息

Moharana Alok Kumar, Gaur Mahendra, Mohapatra Tapas Kumar, Dash Rudra Narayan, Subudhi Bharat Bhusan

机构信息

Drug Development and Analysis Lab, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, 751029, India.

Nityananada College of Pharmacy, Sergarh, Balasore, Odisha, 756060, India.

出版信息

Curr Comput Aided Drug Des. 2025;21(2):194-210. doi: 10.2174/0115734099307360240731052835.

DOI:10.2174/0115734099307360240731052835
PMID:39108124
Abstract

INTRODUCTION

Arthritis is the cause of morbidity associated with Chikungunya virus (CHIKV) infection. It persists even after the virus has been cleared from the body. MBZM-NIBT was earlier shown to inhibit (CHIKV) infection and .

OBJECTIVES

The objective of this study is to determine the ability of MBZM-N-IBT to manage arthritis independent of CHIKV infection.

METHODS

The acute toxicity of MBZM-N-IBT was determined to find a permissible oral dose. Effects against inflammation and arthritis were determined in relevant preclinical models. Network pharmacology was used to propose possible modes of action.

RESULTS

It showed no acute toxicity orally, with an estimated LD of more than 5000 mg/kg in rats. It significantly reduced inflammation. Its effect against Complete Freund's Adjuvant (CFA) induced arthritis was comparable to that of Diclofenac sodium. Network pharmacology analysis revealed that MBZM-N-IBT can potentially interfere with multiple targets and pathways. MMP12 and CTSD were found to be the most probable hub targets of MBZM-N-IBT for its effect against arthritis.

CONCLUSION

In conclusion, MBZM-N-IBT is safe at 50 mg/kg and can manage arthritis independent of CHIKV infection through modulation of multiple pathways and arthritis-associated targets.

摘要

引言

关节炎是与基孔肯雅病毒(CHIKV)感染相关的发病原因。即使病毒已从体内清除,关节炎仍会持续存在。先前研究表明MBZM-NIBT可抑制CHIKV感染。

目的

本研究的目的是确定MBZM-N-IBT在不依赖CHIKV感染的情况下控制关节炎的能力。

方法

测定MBZM-N-IBT的急性毒性以确定允许的口服剂量。在相关临床前模型中确定其对炎症和关节炎的影响。采用网络药理学方法推测可能的作用模式。

结果

口服时无急性毒性,大鼠的估计半数致死量超过5000 mg/kg。它能显著减轻炎症。其对完全弗氏佐剂(CFA)诱导的关节炎的作用与双氯芬酸钠相当。网络药理学分析表明,MBZM-N-IBT可能会干扰多个靶点和途径。发现基质金属蛋白酶12(MMP12)和组织蛋白酶D(CTSD)是MBZM-N-IBT抗关节炎作用最可能的核心靶点。

结论

总之,MBZM-N-IBT在50 mg/kg时是安全的,并且可以通过调节多种途径和与关节炎相关的靶点来控制不依赖CHIKV感染的关节炎。

相似文献

1
Network Pharmacology, Molecular Docking and -based Analysis on the Effects of the MBZM-N-IBT for Arthritis.基于网络药理学、分子对接的MBZM-N-IBT对关节炎作用的分析
Curr Comput Aided Drug Des. 2025;21(2):194-210. doi: 10.2174/0115734099307360240731052835.
2
MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity , , and .MBZM-N-IBT,一种新型小分子,通过靶向 nsP2 蛋白酶活性来限制基孔肯雅病毒感染。
Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0046322. doi: 10.1128/aac.00463-22. Epub 2022 Jun 29.
3
Inhibition of herpes simplex virus-1 infection by MBZM-N-IBT: in silico and in vitro studies.MBZM-N-IBT 抑制单纯疱疹病毒-1 感染的体内外研究。
Virol J. 2021 May 26;18(1):103. doi: 10.1186/s12985-021-01581-5.
4
Inhibition of Chikungunya Virus Replication by 1-[(2-Methylbenzimidazol-1-yl) Methyl]-2-Oxo-Indolin-3-ylidene] Amino] Thiourea(MBZM-N-IBT).1-[(2-甲基苯并咪唑-1-基)甲基]-2-氧代吲哚-3-亚基]氨基]硫脲(MBZM-N-IBT)对基孔肯雅病毒复制的抑制作用
Sci Rep. 2016 Feb 4;6:20122. doi: 10.1038/srep20122.
5
Exploring molecular mechanism of Panlongqi Tablet (PLQT) against RA: Integrated network pharmacology, molecular docking and experiment validation.探索盘龙七片(PLQT)抗类风湿关节炎的分子机制:综合网络药理学、分子对接及实验验证
Int Immunopharmacol. 2025 Jan 10;144:113639. doi: 10.1016/j.intimp.2024.113639. Epub 2024 Nov 30.
6
Integrating lipid metabolomics, serum medicinal chemistry, network pharmacology and experimental validation to explore the mechanism of Sanmiao wan in the treatment of rheumatoid arthritis.整合脂质代谢组学、血清药物化学、网络药理学和实验验证以探究三妙丸治疗类风湿关节炎的机制。
J Ethnopharmacol. 2025 Jan 31;340:119295. doi: 10.1016/j.jep.2024.119295. Epub 2024 Dec 27.
7
Unveiling the mechanism of amelioration of adjuvant-induced rheumatoid arthritis by Drynaria quercifolia rhizome extract using network pharmacology and gene expression-based studies.利用网络药理学和基于基因表达的研究揭示槲蕨根茎提取物改善佐剂诱导的类风湿性关节炎的机制
Sci Rep. 2025 Apr 8;15(1):11981. doi: 10.1038/s41598-025-87461-2.
8
Exploring the mechanism of Sendeng-4 against rheumacid arthritis through integrated serum pharmacochemistry, transcriptomics, and network pharmacology.通过整合血清药代化学、转录组学和网络药理学研究四妙勇安汤抗类风湿性关节炎的作用机制。
Biomed Chromatogr. 2024 Aug;38(8):e5893. doi: 10.1002/bmc.5893. Epub 2024 Jun 10.
9
High-Throughput Metabolomics Integrated Network Pharmacology Reveals the Underlying Mechanism of Paeoniae Radix Alba Treating Rheumatoid Arthritis.高通量代谢组学整合网络药理学揭示白芍治疗类风湿关节炎的潜在机制。
Molecules. 2022 Oct 18;27(20):7014. doi: 10.3390/molecules27207014.
10
Deciphering farnesol's anti-arthritic and immunomodulatory potential by targeting multiple pathways: a combination of network pharmacology guided exploration and experimental verification.通过靶向多种途径解析法尼醇的抗关节炎和免疫调节潜力:网络药理学引导探索与实验验证相结合
J Pharm Pharmacol. 2025 Jan 6;77(1):127-141. doi: 10.1093/jpp/rgae126.

引用本文的文献

1
MMP-12 and Periodontitis: Unraveling the Molecular Pathways of Periodontal Tissue Destruction.基质金属蛋白酶-12与牙周炎:揭示牙周组织破坏的分子途径
J Inflamm Res. 2024 Oct 28;17:7793-7806. doi: 10.2147/JIR.S480466. eCollection 2024.

本文引用的文献

1
Extract Enhances Dextromethorphan Bioavailability: Implications for Alzheimer's Disease.提取物可提高右美沙芬的生物利用度:对阿尔茨海默病的影响
ACS Omega. 2024 May 22;9(22):23634-23648. doi: 10.1021/acsomega.4c01219. eCollection 2024 Jun 4.
2
Salicylic Acid Conjugate of Telmisartan Inhibits Chikungunya Virus Infection and Inflammation.替米沙坦的水杨酸共轭物抑制基孔肯雅病毒感染和炎症。
ACS Omega. 2023 Dec 21;9(1):146-156. doi: 10.1021/acsomega.3c00763. eCollection 2024 Jan 9.
3
Matrix metalloproteinases in arthritis: towards precision medicine.
关节炎中的基质金属蛋白酶:迈向精准医学。
Nat Rev Rheumatol. 2023 Jun;19(6):363-377. doi: 10.1038/s41584-023-00966-w. Epub 2023 May 9.
4
TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages.Toll 样受体 4 是基孔肯雅病毒包膜蛋白 E2 的受体之一,调节宿主巨噬细胞中病毒诱导的促炎反应。
Front Immunol. 2023 Apr 20;14:1139808. doi: 10.3389/fimmu.2023.1139808. eCollection 2023.
5
Conjugates of ibuprofen inhibit CHIKV infection and inflammation.布洛芬缀合物抑制 CHIKV 感染和炎症。
Mol Divers. 2024 Jun;28(3):1261-1272. doi: 10.1007/s11030-023-10654-2. Epub 2023 Apr 21.
6
Synthesis and Anti-Inflammatory Activity Evaluation of Some Benzimidazole Derivatives.某些苯并咪唑衍生物的合成与抗炎活性评估
Pharm Chem J. 2022;56(8):1070-1074. doi: 10.1007/s11094-022-02755-3. Epub 2022 Nov 10.
7
MBZM-N-IBT, a Novel Small Molecule, Restricts Chikungunya Virus Infection by Targeting nsP2 Protease Activity , , and .MBZM-N-IBT,一种新型小分子,通过靶向 nsP2 蛋白酶活性来限制基孔肯雅病毒感染。
Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0046322. doi: 10.1128/aac.00463-22. Epub 2022 Jun 29.
8
In Silico Structure-Based Approach for Group Efficiency Estimation in Fragment-Based Drug Design Using Evaluation of Fragment Contributions.基于片段的药物设计中基于结构的群组效率预估的计算方法:利用片段贡献评估。
Molecules. 2022 Mar 18;27(6):1985. doi: 10.3390/molecules27061985.
9
Exploring the role of cathepsin in rheumatoid arthritis.探索组织蛋白酶在类风湿性关节炎中的作用。
Saudi J Biol Sci. 2022 Jan;29(1):402-410. doi: 10.1016/j.sjbs.2021.09.014. Epub 2021 Sep 13.
10
Telmisartan Restricts Chikungunya Virus Infection and through the AT1/PPAR-γ/MAPKs Pathways.替米沙坦通过 AT1/PPAR-γ/MAPKs 通路限制基孔肯雅病毒感染。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0148921. doi: 10.1128/AAC.01489-21. Epub 2021 Nov 8.